Moreover,
Uganda: 1st non -prone vaccine:
The first non -prone vaccine that can be used in babies has been approved. Moreover, by Swiss medical authorities.
This advancement comes within the framework of a procedure accelerated with the World Health Organization for urgent use in countries like Uganda. Furthermore, where malaria is the deadliest disease. For example, So far. Available vaccines only suited older children, which could cause overdose in infants and babies under 5 kilos, because their liver was not yet developed.
“We are starting to receive children under 6 months old with malaria. Some were born with malaria. this is what we call congenital malaria, others arrive with an infection, infections during the neonatal period, that is to say for a month, and the treatment was quite difficult because we gave them the dose which is given to those who weigh between 5 kg and 14 kg, which uganda: 1st non -prone vaccine was a little difficult and the key question was to know what was the good amount for their kilos? Because normally these children weigh less than 5 kg like newborns, most of them weigh between 2.5 and 4.5 kg. “Said Jane Nabakooza, pediatrician, malaria control program in Uganda.
The new drug approved by the Swiss authorities. known as Coartem Baby in certain countries and Riamet Baby in others, is a combination of two antimalaudic. It is a lower dosed version of a previously approved tablet for other age groups, including older children.
“… You find that doctors are now based on assumptions. they are unable to provide the drugs with these babies to meet their needs with precision and therefore now that we have these new drugs, we will be able to meet a need for a gap, otherwise before the risk was that when you do not give uganda: 1st non -prone vaccine specific treatment, we see the increase in antimalarial resistance, which means Not as they should because of certain things such as dosages that are not exact for babies. “, Akumu Patience, Roll Back Malaria (RBM) partnership said.
In addition to Uganda. the drug will be deployed in Burkina Faso, Côte d’Ivoire, Kenya, Malawi, Mozambique, Nigeria and Tanzania, according to Malaria Consortium, a non -profit organization based in London.
Uganda: 1st non -prone vaccine
Further reading: Drugs: Do people really consume what they think is consuming? – “Eating fries multiplies diabetes by 1.27”: Harvard alerts the hidden danger of fried potatoes and recommends full cereals – Would sunglasses promote skin cancer? It’s obviously false – Here is what to avoid doing so as not to have dry eyes this summer according to an ophthalmologist – The seven pillars of sexual health consultation.
